Galectin 9/LGALS9, His, Human

Galectin 9/LGALS9, His, Human

Galectin-9 is a secreted carbohydrate-binding protein with two lectin domains connected by a linker region.Galectins are a family of proteins defined by their binding specificity for β-galactoside sugars, such as N-acetyllactosamine , which can be bound to proteins by either N-linked or O-linked glycosylation.
Z05326
¥69,021.00

Ask us a question
Product Introduction
Species Human
Protein Construction
His Galectin 9/LGALS9 (Ala2-Thr323)
Accession # O00182-2
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 36.9 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-65 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in 20 mM MOPS, 50 mM NaCl, 1 mM EDTA, 2 mM DTT (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Background
Target Background Galectin-9 is a secreted carbohydrate-binding protein with two lectin domains connected by a linker region.Galectins are a family of proteins defined by their binding specificity for β-galactoside sugars, such as N-acetyllactosamine , which can be bound to proteins by either N-linked or O-linked glycosylation.
Synonyms Ecalectin; GAL9; gal-9; Galectin9; Galectin-9; HUAT; LGALS9; LGALS9A; MGC117375; MGC125973; MGC125974

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.